Article

Best place to retire: Florida, Costa Rica or Mars?

By Peter J. McDonnell, MD

 

Elon Musk-the billionaire tech entrepreneur-asserts “the future of humanity is going to bifurcate. Either it’s going to become multiplanetary, or it’s going to remain confined to one planet and eventually there’s going to be an extinction event.”

Possible catalysts for causing our extinction, he thinks, includes Iranian nukes, engineered viruses, or a wayward asteroid.1 Probably some would add food from Chipotle to this list. But whatever the exact precipitating event, Musk has planned a solution. He will retire on Mars.

 

Unusual retirement choice

Mars differs from Florida in many ways, though it is known the indigenous inhabitants of our neighbor planet have the same unearthly green hue as the golf pants of many Florida retirees.

Musk is considered a charismatic visionary by many, who think he can accomplish anything he sets his mind to, including building internet companies, electric vehicles, and space rockets that land on barges in the ocean.

But there are some major hurdles for Musk’s Mars project. One of particular interest to ophthalmologists is the risk to the vision of those who are exposed to the weightlessness of space for prolonged periods. A recent study seemed to confirm the problem relates to intracranial pressure.2

 

 

 

Scientists at UT Southwestern Medical Center enlisted patients who had been cured of cancers with the aid of permanently implanted Ommaya reservoirs-devices that facilitate the introduction of medicines into the cerebrospinal fluid (CSF) or the removal of excess CSF. This device allowed the measurement of intracranial pressure in real time while subjects were in 20-second periods of weightlessness aboard the NASA parabolic aircraft (aka “the vomit comet”).

CSF pressure is higher in low gravity than when patients are standing or sitting on earth, although it is somewhat lower than when subjects were sleeping on earth. In the weightlessness of space, the investigators believe, the diurnal changes of CSF pressure seen on earth no longer occur, because human physiology responds as though we are constantly lying down.

All people floating in space don’t seem to suffer ill effects from this but some do, and according to NASA, the changes can be permanent. In 2005, after 6 months on the International Space Station, astronaut John Phillips landed on earth with an acuity of 20/100. After 6 months back on mother earth, his vision had only improved “a little” and he now wears glasses. Scott Kelly spent a full year in space, and he went from having uncorrected acuity exceeding 20/20 to being spectacle-dependent (details are not given).

Phillips-we are told in an article3 in The Atlantic with the disturbing (to me) title of “Would You Give Up Perfect Vision for a Trip to Space?”-says the opportunity to be in space was worth the permanent decrease in vision. I suppose some might be tempted to say the trade is a reasonable one: Accept a significant likelihood of permanent loss of vision in return for the opportunity to be a pioneer in space travel.

To me, however, the ethics of a space agency-governmental (like NASA) or private (like Musk’s SpaceX)-allowing young astronauts to knowingly put themselves in that situation is not acceptable. What happened to the gravity simulation from centripetal forces generated by rotating-space vehicles or other strategies to provide the environment our physiologies apparently require? 

 

References

1. http://www.collective-evolution.com/2015/01/26/this-guy-is-planning-to-retire-on-mars-we-have-little-doubt-he-can-make-it-happen/

2. Lawley JS et al. Effect of gravity and microgravity on intracranial pressure. The Journal of Physiology. 16 Jan. 2017. Doi:10.1113/JP273557

3. https://www.theatlantic.com/science/archive/2017/01/seeing-in-space/513650/v

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.